BPA for ycanth

Ended Awarded Last action

Contract number
36E79724A0027
Awardee
Awarding agency
Task orders
0

Award facts

Opportunity
  • VA797P12Q0002 Solicitation number
Last date to order 100% complete
IDV ceiling
$1,250,000.00
Award type
Single award
Who can order
Only the awarding agency
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price

Award details come from SAM.gov/FPDS.

About this IDV

The Blanket Purchase Agreement (BPA) was awarded by the Department of Veterans Affairs (VA) National Acquisition Center, a civilian federal agency, to Verrica Pharmaceuticals Inc. (UEI: FE7QAQRN77H1) on August 16, 2024, under a single award with no set-aside provisions. The contract carries a ceiling value of $1,250,000 and operates under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS) 61-IB. The BPA established a simplified ordering mechanism for the pharmaceutical product YCANTH, enabling VA medical centers and other authorized ordering activities to procure this pharmaceutical directly from the contractor throughout the period of performance. The arrangement streamlines acquisition processes by pre-establishing pricing and terms, thereby reducing procurement lead times and administrative burden for recurring pharmaceutical requirements across the VA's healthcare system.

The BPA is effective through October 30, 2025, representing a one-year ordering period that enables the VA to fulfill patient care pharmaceutical requirements without issuing individual purchase orders for each transaction. Verrica Pharmaceuticals, which specializes in dermatology and hematology-related pharmaceutical products, leverages this contract vehicle alongside complementary Federal Supply Schedule contracts to serve as an approved pharmaceutical supplier to the VA healthcare network. This single-award BPA complements the contractor's existing FSS schedule contract and interim agreements, collectively establishing a comprehensive procurement framework that allows the VA to access qualified pharmaceutical products efficiently while maintaining compliance with federal acquisition regulations and the VA's supply chain management objectives.

Transactions

Action Obligated Date
Legal Contract Cancellation P00003 · BPA cancellation $0
Exercise an Option P00002 · Exercise option year 1 $0
Supplemental Agreement for work within scope P00001 · 2025 public law updates $0
Original award $0

Quick answers

Who was awarded contract 36E79724A0027?

36E79724A0027 was awarded to Verrica Pharmaceuticals Inc. by National Acquisition Center (Headquarters) on August 16, 2024.

How much is contract 36E79724A0027 worth?

36E79724A0027's own ceiling is $1,250,000.

Who can order from contract 36E79724A0027?

36E79724A0027 is a single award blanket purchase agreement. Only the awarding agency can place orders on it.

Is contract 36E79724A0027 under another contract?

Yes. 36E79724A0027 is a blanket purchase agreement under 36F79724D0068, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36E79724A0027 competed?

The extent of competition for 36E79724A0027 was full and open competition. The government received 1 offer.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV